Research Areas
| 3 min read
Ovarian tumors are extremely difficult to get rid of. Scientists are figuring out how to leverage the immune system to help.As lipid nanoparticles become promising drug carriers, understanding their potential genotoxic risks is crucial.
| 3 min read
An immune checkpoint inhibitor and chemotherapy extended progression-free survival in late-stage small cell bladder and prostate cancers.Learn how innovative protein design and engineering are leading the way to transformative treatment modalities.
| 4 min read
Mesenchymal stem cells form nanotubes with and donate mitochondria to T cells, boosting the immune cells’ cancer fighting abilities.
| 3 min read
Two mutations in the BRCA1 gene greatly increase the risk of breast cancer. Now, it seems that only one mutation can help cells tip toward a cancerous edge.
| 3 min read
Takara Bio USA enhances single-cell omics with Curio Bioscience acquisition, expanding spatial biology solutions.
| 3 min read
Researchers developed a new pill with promising applications for treating pain due to gastrointestinal disorders.
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
| 4 min read
Industry leaders name the clinical trials and developments they’re most excited to see in the new year.
Discover new advancements in modeling amyotrophic lateral sclerosis.
| 3 min read
A small percentage of cells in healthy breast tissue show chromosomal abnormalities often linked to cancer, a finding with potential diagnostic implications.
Page 1 of 1097 - 10962 Total Items
Popular Topics
Multimedia
As lipid nanoparticles become promising drug carriers, understanding their potential genotoxic risks is crucial.
Learn how innovative protein design and engineering are leading the way to transformative treatment modalities.
Understand how the tumor microenvironment changes with age and contributes to cancer progression.
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe